Completed OBSERVATIONAL NCT03967028

Indication of Ceaseran Section in Primigravida According to Robson's Classification

Sponsor: Assiut University

Updated 8 times since 2019 Last updated: May 6, 2022 Started: Nov 5, 2019 Primary completion: Sep 30, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03967028, this observational or N/A phase trial focuses on CESAREAN SECTION and remains completed. Sponsored by Assiut University, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
May 2021 — Jun 2022 [monthly]

Recruiting
Jan 2021 — May 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Apr 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Nov 2019 — Apr 2020 [monthly]

Not Yet Recruiting
Jun 2019 — Nov 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Assiut, Egypt